LB Pharmaceuticals has shared top-line data from a phase 2 schizophrenia trial, touting results that offer early support for its vision and putting it on track to start a pivotal study around the end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback